Both enantiomers (with IC50 values of 0.40 and 0.44 mM, respectively) have the potential to act as antagonists of acetylcholinesterase and could be of interest in the field of Alzheimer’s disease treatment [44]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.